Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-24 4:14 pm Purchase | 2022-10-14 | 13G | HUDSON ACQUISITION I CORP UNIT HUDAU | L1 Capital Global Opportunities Master Fund, Ltd. | 475,000 6.050% | 475,000 (New Position) | Filing History |
| 2022-07-22 5:17 pm Purchase | 2022-07-18 | 13G | PERFORMANCE SHIPPING INC PSHG | L1 Capital Global Opportunities Master Fund, Ltd. | 100,000 5.500% | 100,000 (New Position) | Filing History |
| 2022-02-14 5:13 pm Purchase | 2021-12-31 | 13G | AMERICAN INTERNATIONAL HOLDING AMIH | L1 Capital Global Opportunities Master Fund, Ltd. | 134,688 9.900% | 60,105 (+80.59%) | Filing History |
| 2022-02-11 5:51 pm Purchase | 2022-01-18 | 13G | BRIACELL THERAPEUTICS INC BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 4,123 4.200% | 3,423 (+489.00%) | Filing History |
| 2022-02-11 5:50 pm Unchanged | 2021-12-31 | 13G | CREATIVE MED TECHNOLOGY HLDGS CELZ | L1 Capital Global Opportunities Master Fund, Ltd. | 32,746 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-11 5:49 pm Sale | 2021-12-31 | 13G | LEXARIA BIOSCIENCE CORP COM PA LEXX | L1 Capital Global Opportunities Master Fund, Ltd. | 10,600 2.600% | -8,448 (-44.35%) | Filing History |
| 2022-02-11 5:49 pm Sale | 2021-12-31 | 13G | SEANERGY MARITIME HOLDINGS COR SHIP | L1 Capital Global Opportunities Master Fund, Ltd. | 25,000 0.001% | -21,875 (-46.67%) | Filing History |
| 2022-02-11 5:48 pm Sale | 2021-12-31 | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | L1 Capital Global Opportunities Master Fund, Ltd. | 24,736 4.990% | -9,327 (-27.38%) | Filing History |
| 2022-02-11 5:48 pm Sale | 2021-12-31 | 13G | GEOVAX LABS INC PAR $.0001 GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -1,024 (Position Closed) | Filing History |
| 2022-02-11 5:47 pm Sale | 2021-12-31 | 13G | BRIACELL THERAPEUTICS INC BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 700 11.000% | -5,967 (-89.50%) | Filing History |
| 2021-12-08 5:00 pm Purchase | 2021-12-07 | 13G | CREATIVE MED TECHNOLOGY HLDGS CELZ | L1 Capital Global Opportunities Master Fund, Ltd. | 32,746 5.100% | 32,746 (New Position) | Filing History |
| 2021-11-18 4:30 pm Purchase | 2021-07-02 | 13G | RECRUITER COM GROUP INC RCRT | L1 Capital Global Opportunities Master Fund, Ltd. | 70,195 7.300% | 70,195 (New Position) | Filing History |